Creating a malaria vaccine that protects against multiple strains
Designing a diversity-covering multiantigen multi-strain malaria vaccine
This study is working on a new malaria vaccine that could help protect people from different types of the malaria parasite, and it's being led by Dr. Amed Ouattara, who is learning more about how to create effective vaccines.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10677013 on NIH RePORTER |
What this research studies
This research aims to develop a malaria vaccine that can provide protection against various strains of the malaria parasite. The project is led by Dr. Amed Ouattara, who is training in immunology and vaccinology to enhance his expertise in this area. The approach involves designing a multi-antigen vaccine that can elicit a strong immune response across different malaria strains, potentially improving vaccine efficacy. The research team includes experienced mentors in immunology and malaria, ensuring a robust training and research environment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in malaria-endemic regions, particularly in Africa and Asia, who are at risk of malaria infection.
Not a fit: Patients who do not live in malaria-endemic areas or those who are not at risk of malaria infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective malaria vaccine that protects against multiple strains, reducing the incidence of malaria infections.
How similar studies have performed: Previous research has shown promise in developing multi-strain vaccines for other infectious diseases, indicating potential for success in this novel approach to malaria vaccination.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Ouattara, Amed — University of Maryland Baltimore
- Study coordinator: Ouattara, Amed
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.